The structure of milestone payments generally includes initial funding followed by subsequent payments linked to specific achievements. These achievements can range from successful clinical trials and regulatory approvals to market launch and sales targets. For instance, a company might receive an initial sum to start the research, followed by separate payments upon reaching Phase I, Phase II, and Phase III of clinical trials.